[Specificity of pharmacological trials and the idea of target structures].
D000818:Animals; D002415:Cats; D006632:Histamine / Q000378:metabolism; D006634:Histamine H1 Antagonists / Q000494:pharmacology*; D008722:Methods; D051379:Mice; D009119:Muscle Contraction; D009466:Neuromuscular Blocking Agents / Q000494:pharmacology; D009467:Neuromuscular Depolarizing Agents / Q000494:pharmacology; D009469:Neuromuscular Junction / Q000378:metabolism; D003473:Neuromuscular Nondepolarizing Agents / Q000494:pharmacology*; D011817:Rabbits; D051381:Rats
D006634:Histamine H1 Antagonists; D009466:Neuromuscular Blocking Agents; D009467:Neuromuscular Depolarizing Agents; D003473:Neuromuscular Nondepolarizing Agents; D006632:Histamine
Spécificité des essais pharmacologiques et notion de structure cible